(ATRO) Astronics - Overview
Stock: Lighting, Power, Avionics, Test, Simulation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 54.0% |
| Relative Tail Risk | -22.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.64 |
| Alpha | 295.79 |
| Character TTM | |
|---|---|
| Beta | 1.044 |
| Beta Downside | 0.938 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.89% |
| CAGR/Max DD | 2.22 |
Description: ATRO Astronics January 20, 2026
Astronics Corporation (NASDAQ: ATRO) designs and manufactures aerospace, defense, and electronics products through two operating segments: Aerospace and Test Systems. The Aerospace segment supplies lighting, safety, power generation, distribution, seat-motion, structural, and avionics solutions to commercial, military, and general-aviation OEMs, airlines, and U.S. Department of Defense customers. The Test Systems segment builds automated test equipment, training simulators, and related services for aerospace, defense, communications, and mass-transit markets, primarily serving OEMs and prime government contractors.
Key operating metrics (FY 2024) show total revenue of approximately $1.05 billion, with the Aerospace segment contributing about 68 % and Test Systems the remaining 32 %. The company reported a 4.5 % year-over-year revenue increase, driven largely by higher defense spend and a modest rebound in commercial aircraft orders after the pandemic-induced slowdown. The backlog at year-end stood near $1.2 billion, indicating a multi-quarter pipeline of contracted work.
Sector drivers that materially affect ATRO’s outlook include: (1) sustained U.S. defense budget growth-projected to rise ~2.5 % annually through 2028, bolstering demand for certified test equipment and avionics; (2) the recovery of commercial air travel, which underpins OEM demand for cabin lighting, seat-motion, and power-distribution systems; and (3) supply-chain constraints on semiconductor components, which can pressure margins on avionics and test-system products.
Investors seeking a deeper, data-driven view of Astronics’ valuation and risk profile may find it worthwhile to explore the analytics platform ValueRay for additional quantitative insights.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -3.09m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 8.19 > 1.0 |
| NWC/Revenue: 33.91% < 20% (prev 35.05%; Δ -1.14% < -1%) |
| CFO/TA 0.11 > 3% & CFO 74.3m > Net Income -3.09m |
| Net Debt (365.9m) to EBITDA (39.6m): 9.25 < 3 |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.4m) vs 12m ago 1.18% < -2% |
| Gross Margin: 27.48% > 18% (prev 0.24%; Δ 2724 % > 0.5%) |
| Asset Turnover: 124.5% > 50% (prev 120.0%; Δ 4.51% > 0%) |
| Interest Coverage Ratio: 1.32 > 6 (EBITDA TTM 39.6m / Interest Expense TTM 13.3m) |
Altman Z'' 4.00
| A: 0.41 (Total Current Assets 432.6m - Total Current Liabilities 151.0m) / Total Assets 682.2m |
| B: 0.28 (Retained Earnings 192.2m / Total Assets 682.2m) |
| C: 0.03 (EBIT TTM 17.6m / Avg Total Assets 666.9m) |
| D: 0.19 (Book Value of Equity 108.9m / Total Liabilities 573.3m) |
| Altman-Z'' Score: 4.00 = AA |
Beneish M -3.33
| DSRI: 0.92 (Receivables 188.6m/193.5m, Revenue 830.6m/782.2m) |
| GMI: 0.86 (GM 27.48% / 23.75%) |
| AQI: 0.94 (AQ_t 0.17 / AQ_t-1 0.19) |
| SGI: 1.06 (Revenue 830.6m / 782.2m) |
| TATA: -0.11 (NI -3.09m - CFO 74.3m) / TA 682.2m) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of ATRO shares?
Over the past week, the price has changed by +1.10%, over one month by +28.75%, over three months by +62.90% and over the past year by +306.04%.
Is ATRO a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATRO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77 | 0.5% |
| Analysts Target Price | 77 | 0.5% |
| ValueRay Target Price | 118.2 | 54.3% |
ATRO Fundamental Data Overview February 07, 2026
P/S = 3.1485
P/B = 24.0193
P/EG = 1.4638
Revenue TTM = 830.6m USD
EBIT TTM = 17.6m USD
EBITDA TTM = 39.6m USD
Long Term Debt = 334.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.02m USD (from shortTermDebt, last quarter)
Debt = 379.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 365.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.98b USD (2.62b + Debt 379.4m - CCE 13.5m)
Interest Coverage Ratio = 1.32 (Ebit TTM 17.6m / Interest Expense TTM 13.3m)
EV/FCF = 58.13x (Enterprise Value 2.98b / FCF TTM 51.3m)
FCF Yield = 1.72% (FCF TTM 51.3m / Enterprise Value 2.98b)
FCF Margin = 6.17% (FCF TTM 51.3m / Revenue TTM 830.6m)
Net Margin = -0.37% (Net Income TTM -3.09m / Revenue TTM 830.6m)
Gross Margin = 27.48% ((Revenue TTM 830.6m - Cost of Revenue TTM 602.4m) / Revenue TTM)
Gross Margin QoQ = 30.51% (prev 25.81%)
Tobins Q-Ratio = 4.37 (Enterprise Value 2.98b / Total Assets 682.2m)
Interest Expense / Debt = 0.77% (Interest Expense 2.92m / Debt 379.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = 13.9m (EBIT 17.6m * (1 - 21.00%))
Current Ratio = 2.87 (Total Current Assets 432.6m / Total Current Liabilities 151.0m)
Debt / Equity = 3.48 (Debt 379.4m / totalStockholderEquity, last quarter 108.9m)
Debt / EBITDA = 9.25 (Net Debt 365.9m / EBITDA 39.6m)
Debt / FCF = 7.13 (Net Debt 365.9m / FCF TTM 51.3m)
Total Stockholder Equity = 225.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.46% (Net Income -3.09m / Total Assets 682.2m)
RoE = -1.37% (Net Income TTM -3.09m / Total Stockholder Equity 225.8m)
RoCE = 3.14% (EBIT 17.6m / Capital Employed (Equity 225.8m + L.T.Debt 334.0m))
RoIC = 3.21% (NOPAT 13.9m / Invested Capital 431.4m)
WACC = 8.60% (E(2.62b)/V(2.99b) * Re(9.76%) + D(379.4m)/V(2.99b) * Rd(0.77%) * (1-Tc(0.21)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.78%
[DCF Debug] Terminal Value 67.53% ; FCFF base≈51.3m ; Y1≈33.7m ; Y5≈15.4m
Fair Price DCF = N/A (negative equity: EV 271.8m - Net Debt 365.9m = -94.1m; debt exceeds intrinsic value)
EPS Correlation: 65.82 | EPS CAGR: 6.42% | SUE: -2.62 | # QB: 0
Revenue Correlation: 60.53 | Revenue CAGR: 17.35% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=+0.019 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=2.52 | Chg30d=+0.113 | Revisions Net=+4 | Growth EPS=+34.8% | Growth Revenue=+12.6%